Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187733 · ClinicalTrials.gov registry record
Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 16
- Enrollment target
NCT00187733: Completed study, sponsored by University of California, San Francisco.
NCT00187733 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00187733 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The current study is part of a large multi-investigator grant to look at the pharmacogenetics of a number of membrane transporters. Previously, the investigators have recruited a cohort of healthy volunteers (Studies of Pharmacogenetics in Ethnically-Diverse Populations, or SOPHIE) and have resequenced the coding region of a number of membrane transporter genes to identify genetic polymorphisms in these genes. Subjects in this cohort have agreed to be called back for recruitment in further studies based on their own genetic sequence, allowing the investigators the possibility to prospectively study the influence of genetic polymorphisms on particular phenotypes (i.e., genotype-to-phenotype studies). The investigators plan to take a genotype-to-phenotype approach to study the influence of specific polymorphisms in the novel organic cation transporter 2 (OCTN2) gene on carnitine and lipid metabolism in healthy subjects.
Interventions
- OTHER Fasting blood and urine collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-02 |
What the finished NCT00187733 record still lists
NCT00187733 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fasting blood and urine collection is the first listed.
NCT00187733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00187733 about?
NCT00187733 is a clinical study titled "Influence of OCTN2 Variants on Carnitine Status and Plasma Triglycerides". The current study is part of a large multi-investigator grant to look at the pharmacogenetics of a number of membrane transporters. Previously, the investigators have recruited a cohort of healthy volunteers (Studies of Pharmacogenetics in Ethnically-Diverse Populations, or SOPHIE) and have resequen...
What is the current status of trial NCT00187733?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2005-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00187733?
The interventions under investigation include: Fasting blood and urine collection (OTHER).
Who is sponsoring clinical trial NCT00187733?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia